 | | 60H | | Name: | (2~{S})-2-(diphenylmethyl)pyrrolidine | | Formula: | C17 H19 N | | SMILES: | C1CN[CH](C1)C(c2ccccc2)c3ccccc3 | | InChi: | InChI=1S/C17H19N/c1-3-8-14(9-4-1)17(16-12-7-13-18-16)15-10-5-2-6-11-15/h1-6,8-11,16-18H,7,12-13H2/t16-/m0/s1 | | Definition date: | 2016-01-08 | | Last modified: | 2023-11-03 | | Release date: | 2016-01-27 | | Identifier: | (2~{S})-2-(diphenylmethyl)pyrrolidine |
|
 | | HS8 | | Name: | 3-(1-sulfo-1H-imidazol-3-ium-4-yl)-L-alanine | | Formula: | C6 H10 N3 O5 S | | SMILES: | O=S(=O)(O)n1cc([nH+]c1)CC(C(=O)O)N | | InChi: | InChI=1S/C6H9N3O5S/c7-5(6(10)11)1-4-2-9(3-8-4)15(12,13)14/h2-3,5H,1,7H2,(H,10,11)(H,12,13,14)/p+1/t5-/m0/s1 | | Definition date: | 2008-11-13 | | Last modified: | 2023-11-03 | | Identifier: | 3-(1-sulfo-1H-imidazol-3-ium-4-yl)-L-alanine |
|
 | | HSE | | Name: | L-HOMOSERINE | | Formula: | C4 H9 N O3 | | SMILES: | O=C(O)C(N)CCO | | InChi: | InChI=1S/C4H9NO3/c5-3(1-2-6)4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1 | | Definition date: | 2000-02-02 | | Last modified: | 2023-11-03 | | Identifier: | L-homoserine |
|
 | | HSK | | Name: | 3-hydroxy-L-histidine | | Formula: | C6 H9 N3 O3 | | SMILES: | O=C(O)C(N)Cc1cncn1O | | InChi: | InChI=1S/C6H9N3O3/c7-5(6(10)11)1-4-2-8-3-9(4)12/h2-3,5,12H,1,7H2,(H,10,11)/t5-/m0/s1 | | Definition date: | 2014-05-01 | | Last modified: | 2023-11-03 | | Release date: | 2014-09-03 | | Identifier: | 3-hydroxy-L-histidine |
|
 | | HSL | | Name: | HOMOSERINE LACTONE | | Formula: | C4 H7 N O2 | | SMILES: | O=C1OCCC1N | | InChi: | InChI=1S/C4H7NO2/c5-3-1-2-7-4(3)6/h3H,1-2,5H2/t3-/m0/s1 | | Definition date: | 2001-11-02 | | Last modified: | 2023-11-03 | | Identifier: | (3S)-3-aminodihydrofuran-2(3H)-one |
|
 | | HSO | | Name: | L-histidinol | | Formula: | C6 H12 N3 O | | SMILES: | NC(CO)Cc1[nH+]cnc1 | | InChi: | InChI=1S/C6H11N3O/c7-5(3-10)1-6-2-8-4-9-6/h2,4-5,10H,1,3,7H2,(H,8,9)/p+1/t5-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2023-11-03 | | Identifier: | 4-[(2S)-2-amino-3-hydroxypropyl]-1H-imidazol-3-ium |
|
 | | HSV | | Name: | L-histidinal | | Formula: | C6 H10 N3 O | | SMILES: | NC(C=O)Cc1[nH+]cnc1 | | InChi: | InChI=1S/C6H9N3O/c7-5(3-10)1-6-2-8-4-9-6/h2-5H,1,7H2,(H,8,9)/p+1/t5-/m0/s1 | | Definition date: | 2015-06-17 | | Last modified: | 2023-11-03 | | Identifier: | 4-[(2S)-2-amino-3-oxopropyl]-1H-imidazol-3-ium |
|
 | | HT0 | | Name: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid | | Formula: | C10 H9 N O5 | | SMILES: | O=C(O)C1NC(=O)OC1c1ccc(O)cc1 | | InChi: | InChI=1S/C10H9NO5/c12-6-3-1-5(2-4-6)8-7(9(13)14)11-10(15)16-8/h1-4,7-8,12H,(H,11,15)(H,13,14)/t7-,8-/m1/s1 | | Definition date: | 2021-03-10 | | Last modified: | 2023-11-03 | | Release date: | 2022-12-07 | | Identifier: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid |
|
 | | HT7 | | Name: | (3S)-3-AMINO-4-(1H-INDOL-3-YL)BUTANOIC ACID | | Formula: | C12 H14 N2 O2 | | SMILES: | O=C(O)CC(N)Cc2c1ccccc1nc2 | | InChi: | InChI=1S/C12H14N2O2/c13-9(6-12(15)16)5-8-7-14-11-4-2-1-3-10(8)11/h1-4,7,9,14H,5-6,13H2,(H,15,16)/t9-/m0/s1 | | Synonyms: | BETA-HOMOTRYPTOPHAN | | Definition date: | 2011-05-18 | | Last modified: | 2023-11-03 | | Identifier: | (3S)-3-amino-4-(1H-indol-3-yl)butanoic acid |
|
 | | HTN | | Name: | (3R)-3-hydroxy-N-methyl-D-asparagine | | Formula: | C5 H10 N2 O4 | | SMILES: | O=C(NC)C(O)C(C(=O)O)N | | InChi: | InChI=1S/C5H10N2O4/c1-7-4(9)3(8)2(6)5(10)11/h2-3,8H,6H2,1H3,(H,7,9)(H,10,11)/t2-,3-/m1/s1 | | Definition date: | 2008-06-03 | | Last modified: | 2023-11-03 | | Identifier: | (3R)-3-hydroxy-N-methyl-D-asparagine |
|
 | | HTR | | Name: | BETA-HYDROXYTRYPTOPHANE | | Formula: | C11 H12 N2 O3 | | SMILES: | O=C(O)C(N)C(O)c2c1ccccc1nc2 | | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)10(14)7-5-13-8-4-2-1-3-6(7)8/h1-5,9-10,13-14H,12H2,(H,15,16)/t9-,10-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2023-11-03 | | Identifier: | (betaS)-beta-hydroxy-L-tryptophan |
|
 | | 62H | | Name: | (2S)-3-amino-2-methylpropanoic acid | | Formula: | C4 H9 N O2 | | SMILES: | NCC(C(=O)O)C | | InChi: | InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1 | | Definition date: | 2016-01-15 | | Last modified: | 2023-11-03 | | Release date: | 2016-02-24 | | Identifier: | (2S)-3-amino-2-methylpropanoic acid |
|
 | | HTY | | Name: | (betaR)-beta-hydroxy-D-tyrosine | | Formula: | C9 H11 N O4 | | SMILES: | O=C(O)C(N)C(O)c1ccc(O)cc1 | | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8-/m1/s1 | | Definition date: | 2002-09-02 | | Last modified: | 2023-11-03 | | Identifier: | (betaR)-beta-hydroxy-D-tyrosine |
|
 | | HVA | | Name: | 3-hydroxy-L-valine | | Formula: | C5 H11 N O3 | | SMILES: | O=C(O)C(N)C(O)(C)C | | InChi: | InChI=1S/C5H11NO3/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m1/s1 | | Synonyms: | L-beta-hydroxyvaline | | Definition date: | 2008-06-02 | | Last modified: | 2023-11-03 | | Identifier: | 3-hydroxy-L-valine |
|
 | | HY1 | | Name: | PHENYLACETALDEHYDE | | Formula: | C8 H8 O | | SMILES: | O=CCc1ccccc1 | | InChi: | InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2 | | Definition date: | 1999-08-26 | | Last modified: | 2023-11-03 | | Identifier: | phenylacetaldehyde |
|
 | | HY3 | | Name: | 3-HYDROXYPROLINE | | Formula: | C5 H9 N O3 | | SMILES: | O=C(O)C1NCCC1O | | InChi: | InChI=1S/C5H9NO3/c7-3-1-2-6-4(3)5(8)9/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4-/m0/s1 | | Synonyms: | (2S,3S)-3-hydroxypyrrolidine-2-carboxylic acid | | Definition date: | 2006-03-22 | | Last modified: | 2023-11-03 | | Identifier: | (3S)-3-hydroxy-L-proline |
|
 | | HYP | | Name: | 4-HYDROXYPROLINE | | Formula: | C5 H9 N O3 | | SMILES: | O=C(O)C1NCC(O)C1 | | InChi: | InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1 | | Synonyms: | HYDROXYPROLINE | | Definition date: | 1999-07-08 | | Last modified: | 2023-11-03 | | Identifier: | (4R)-4-hydroxy-L-proline |
|
 | | HZP | | Name: | (4S)-4-hydroxy-L-proline | | Formula: | C5 H9 N O3 | | SMILES: | O=C(O)C1NCC(O)C1 | | InChi: | InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4-/m0/s1 | | Definition date: | 2009-04-16 | | Last modified: | 2023-11-03 | | Identifier: | (4S)-4-hydroxy-L-proline |
|
 | | I0C | | Name: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[[9-[(2~{R},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-7~{H}-purin-6-yl]amino]propyl]amino]-2-azanyl-butanoic acid | | Formula: | | | SMILES: | N[CH](CCN(CCCNc1ncnc2n(cnc12)C3OC(CO)C(O)C3O)C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)C(O)=O | | InChi: | InChI=1S/C27H38N12O9/c28-12(27(45)46)2-5-37(6-13-17(41)19(43)25(47-13)38-10-35-15-21(29)31-8-33-23(15)38)4-1-3-30-22-16-24(34-9-32-22)39(11-36-16)26-20(44)18(42)14(7-40)48-26/h8-14,17-20,25-26,40-44H,1-7,28H2,(H,45,46)(H2,29,31,33)(H,30,32,34)/t12-,13+,14?,17+,18?,19+,20?,25+,26?/m0/s1 | | Definition date: | 2023-07-24 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[[9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-6-yl]amino]propyl]amino]-2-azanyl-butanoic acid |
|
 | | I1C | | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-iodophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | | Formula: | C15 H16 I N3 O5 | | SMILES: | C(O)(C)C(C2=NC(=[C@H]c1cc(I)c(cc1)O)C(N2CC(O)=O)=O)N | | InChi: | InChI=1S/C15H16IN3O5/c1-7(20)13(17)14-18-10(15(24)19(14)6-12(22)23)5-8-2-3-11(21)9(16)4-8/h2-5,7,13,20-21H,6,17H2,1H3,(H,22,23)/b10-5-/t7-,13+/m1/s1 | | Definition date: | 2019-04-02 | | Last modified: | 2023-11-03 | | Release date: | 2020-04-08 | | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-iodophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | | I2F | | Name: | (2~{S},4~{R},5~{E})-5-[(5~{S})-5-azanyl-6-oxidanyl-hexyl]iminohexane-1,2,4-triol | | Formula: | C12 H26 N2 O5 | | SMILES: | CC(=NCCCC[CH](N)C(O)O)[CH](O)C[CH](O)CO | | InChi: | InChI=1S/C12H26N2O5/c1-8(11(17)6-9(16)7-15)14-5-3-2-4-10(13)12(18)19/h9-12,15-19H,2-7,13H2,1H3/b14-8+/t9-,10-,11+/m0/s1 | | Definition date: | 2022-02-08 | | Last modified: | 2023-11-03 | | Release date: | 2023-02-08 | | Identifier: | (2~{S},4~{R},5~{E})-5-[(5~{S})-5-azanyl-6,6-bis(oxidanyl)hexyl]iminohexane-1,2,4-triol |
|
 | | I2J | | Name: | 2-(2-aminoethoxy)ethan-1-ol | | Formula: | C4 H11 N O2 | | SMILES: | NCCOCCO | | InChi: | InChI=1S/C4H11NO2/c5-1-3-7-4-2-6/h6H,1-5H2 | | Definition date: | 2022-01-07 | | Last modified: | 2023-11-03 | | Release date: | 2022-08-03 | | Identifier: | 2-(2-aminoethoxy)ethan-1-ol |
|
 | | I2M | | Name: | 3-methyl-L-alloisoleucine | | Formula: | C7 H15 N O2 | | SMILES: | O=C(O)C(N)C(C)(CC)C | | InChi: | InChI=1S/C7H15NO2/c1-4-7(2,3)5(8)6(9)10/h5H,4,8H2,1-3H3,(H,9,10)/t5-/m1/s1 | | Synonyms: | beta-methylisoleucine | | Definition date: | 2008-06-01 | | Last modified: | 2023-11-03 | | Identifier: | 3-methyl-L-alloisoleucine |
|
 | | N1U | | Name: | (3S)-5-bromo-1-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-7-methyl-1,3-dihydro-2H-indol-2-one | | Formula: | C18 H18 Br N O4 | | SMILES: | COc1ccc(cc1OC)CN1c2c(C)cc(Br)cc2C(O)C1=O | | InChi: | InChI=1S/C18H18BrNO4/c1-10-6-12(19)8-13-16(10)20(18(22)17(13)21)9-11-4-5-14(23-2)15(7-11)24-3/h4-8,17,21H,9H2,1-3H3/t17-/m0/s1 | | Definition date: | 2023-08-16 | | Last modified: | 2023-11-03 | | Release date: | 2023-11-08 | | Identifier: | (3S)-5-bromo-1-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-7-methyl-1,3-dihydro-2H-indol-2-one |
|
 | | N2C | | Name: | N,S-DIMETHYLCYSTEINE | | Formula: | C5 H11 N O2 S | | SMILES: | O=C(O)C(NC)CSC | | InChi: | InChI=1S/C5H11NO2S/c1-6-4(3-9-2)5(7)8/h4,6H,3H2,1-2H3,(H,7,8)/t4-/m0/s1 | | Definition date: | 2004-11-02 | | Last modified: | 2023-11-03 | | Identifier: | N,S-dimethyl-L-cysteine |
|
